Home > Press > Brock Family Gifts of $1 Million Support Discovery and Advance Patient Care at Emory University
Mary and John Brock |
Abstract:
John Brock, chairman and CEO of Coca-Cola Enterprises, his wife, Mary, and their three children are supporting the health sciences at Emory University with two gifts totaling $1 million.
Recently the Brocks committed $500,000 to support advances in Emory School of Medicine. The gift will establish the John and Mary Brock Diagnostics and Discoveries Fund to Benefit Patients, the goal of which will be to bring novel diagnostic tools into use more quickly. The gift will help researchers and physicians bring nanotechnology discoveries from the lab to the clinic, where they can make a difference for patients, and will create ways to measure the success of these translational applications.
"I am very excited about the opportunity that this generous gift will allow," says internist David L. Roberts, MD, Charles F. Evans Chair in Internal Medicine.
Roberts, an expert in preventive and diagnostic medicine who leads Emory's Executive Health Program, says the gift will provide seed grants for early studies aimed at detecting and preventing clinically significant vascular disease. It also will help create the infrastructure needed to make the Executive Health Program a vital source of clinical material and data that others can access to study disease prevention and overall health.
The fund will help translate into clinical practice the work taking place in Emory's labs, such as the research in cardiovascular nanotechnology being conducted by Roberts' colleague, W. Robert Taylor, MD, PhD, chief of the Division of Cardiology and professor in the Wallace H. Coulter Department of Biomedical Engineering at Georgia Tech and Emory University. Taylor and his colleagues are at work on highly promising diagnostic tools emerging in nanotechnology and offering new hope to those at risk for cardiovascular disease.
____
Earlier this year, the Brocks gave $500,000 to establish the Brock Family Child and Adolescent Mood Disorders Program (CAMP) Fund, which has become integral to the success of the program. The fund allows treatment of uninsured patients who are unable to afford clinical services for their children.
Directed by W. Edward Craighead, PhD, J. Rex Fuqua Professor of Psychiatry and Psychology, CAMP blends basic science, translational science, clinical research and a patient care clinic to facilitate the development of innovative, effective clinical programs for child and adolescent depression, anxiety and bipolar disorders.
CAMP includes training for Emory undergraduate and graduate students, medical residents and postdoctoral fellows who represent the next generation of leaders in the field of child and adolescent psychiatry.
With support from the Brocks' gift, CAMP collaborates with depression prevention programs in Iceland and Portugal, offers a clinical program for non-suicidal self-injurious behavior among adolescents and provides a telepsychiatry program for rural Georgia. The gift also has facilitated a partnership between CAMP and the Women's Mental Health Program at Emory to develop assessment and intervention programs for children whose mothers have been treated for bipolar disorder.
Longtime supporters of Emory University and the Georgia Institute of Technology, the Brocks have philanthropic interests that center on innovative research and translational medicine.
Writer: Jennifer Wheelock
####
For more information, please click here
Contacts:
Holly Korschun
404-727-3990
Copyright © Emory University
If you have a comment, please Contact us.Issuers of news releases, not 7th Wave, Inc. or Nanotechnology Now, are solely responsible for the accuracy of the content.
Related News Press |
News and information
Beyond wires: Bubble technology powers next-generation electronics:New laser-based bubble printing technique creates ultra-flexible liquid metal circuits November 8th, 2024
Nanoparticle bursts over the Amazon rainforest: Rainfall induces bursts of natural nanoparticles that can form clouds and further precipitation over the Amazon rainforest November 8th, 2024
Nanotechnology: Flexible biosensors with modular design November 8th, 2024
Exosomes: A potential biomarker and therapeutic target in diabetic cardiomyopathy November 8th, 2024
Academic/Education
Rice University launches Rice Synthetic Biology Institute to improve lives January 12th, 2024
Multi-institution, $4.6 million NSF grant to fund nanotechnology training September 9th, 2022
Nanomedicine
Exosomes: A potential biomarker and therapeutic target in diabetic cardiomyopathy November 8th, 2024
Unveiling the power of hot carriers in plasmonic nanostructures August 16th, 2024
Announcements
Nanotechnology: Flexible biosensors with modular design November 8th, 2024
Exosomes: A potential biomarker and therapeutic target in diabetic cardiomyopathy November 8th, 2024
Turning up the signal November 8th, 2024
Nanofibrous metal oxide semiconductor for sensory face November 8th, 2024
Grants/Sponsored Research/Awards/Scholarships/Gifts/Contests/Honors/Records
New discovery aims to improve the design of microelectronic devices September 13th, 2024
Physicists unlock the secret of elusive quantum negative entanglement entropy using simple classical hardware August 16th, 2024
Atomic force microscopy in 3D July 5th, 2024
Aston University researcher receives £1 million grant to revolutionize miniature optical devices May 17th, 2024
The latest news from around the world, FREE | ||
Premium Products | ||
Only the news you want to read!
Learn More |
||
Full-service, expert consulting
Learn More |
||